Literature DB >> 29524410

Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer.

Yu Song1, Qisang Guo1, Shujun Gao2, Keqin Hua3.   

Abstract

Many studies have been reported that tripartite motif-containing (TRIM) proteins play important roles in various cellular processes and involved in many diseases. TRIM3, a member of TRIM family, has been proved that it plays important roles in various cancers. Nevertheless, its effects on cervical cancer reminded unknown. This study aimed to explore TRIM3 function in cervical cancer cells. The results of quantitative real-time RT-PCR and western blotting showed that the TRIM3 expression was very low in five cervical cancer cell lines. The TRIM3 overexpression weakened cell viability, and promote apoptosis of C-33A and SiHa cells in vitro, and inhibit tumor growth in vivo, which suggested that TRIM3 could reduce proliferation of cervical cancer cells. Moreover, TRIM3 up-regulation enhanced caspase-3 activity and increased the expressions of cleaved caspase-3 and p53, at the same time decreased p38 phosphorylation level. In addition, TRIM3 down-regulation had opposite effects on cell proliferation and expressions of the three proteins, which could be suppressed by p38-specific inhibitor (SB203580). In conclusion, TRIM3 had the ability to suppress cell proliferation by inactivating p38 signaling pathway, which indicated that it might act as a tumor inhibitor and an underlying therapeutic target for cervical cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Cervical cancer; Tripartite motif-containing protein 3; p38

Mesh:

Substances:

Year:  2018        PMID: 29524410     DOI: 10.1016/j.bbrc.2018.03.046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.

Authors:  Kun Wang; Zhen Chen; Lu Long; Ya Tao; Qiong Wu; Manlin Xiang; Yunlai Liang; Xulin Xie; Yuan Jiang; Zhiqiang Xiao; Yahui Yan; Shiyang Qiu; Bin Yi
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

Review 2.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

3.  Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.

Authors:  Bo Liu; Xiujuan Li; Fengxi Liu; Fengyu Li; Shuxia Wei; Junchao Liu; Yang Lv
Journal:  Pathol Oncol Res       Date:  2018-11-27       Impact factor: 3.201

4.  Expression of the human TRIM14 and its mutant form (P207L) promotes apoptosis in transgenic loaches.

Authors:  Valentina V Nenasheva; Ekaterina A Stepanenko; Irina V Makarova; Nella V Khaidarova; Stanislav A Antonov; Larisa V Kozikova; Ekaterina A Polteva; Galina V Kovaleva; Zeineb Ayed; Anastasia D Vovk; Natalya A Shcherbatova; Lyudmila E Andreeva; Vyacheslav Z Tarantul
Journal:  Mol Biol Rep       Date:  2018-09-10       Impact factor: 2.316

Review 5.  Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Authors:  Hang Su; Weihong Ren; Dai Zhang
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 3.984

Review 6.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

Review 7.  Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling.

Authors:  Anmol Sharma; Heena Khan; Thakur Gurjeet Singh; Amarjot Kaur Grewal; Agnieszka Najda; Małgorzata Kawecka-Radomska; Mohamed Kamel; Ahmed E Altyar; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

8.  TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients.

Authors:  Mohammad Reza Roshanazadeh; Maryam Adelipour; Arash Sanaei; Hadi Chenane; Mojtaba Rashidi
Journal:  BMC Res Notes       Date:  2022-09-30

Review 9.  Tumor suppressor p53 cross-talks with TRIM family proteins.

Authors:  Juan Liu; Cen Zhang; Xue Wang; Wenwei Hu; Zhaohui Feng
Journal:  Genes Dis       Date:  2020-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.